BMY•benzinga•
Cantor Fitzgerald Assumes Bristol-Myers Squibb at Neutral, Announces Price Target of $55
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 22, 2025 by benzinga